R. Christopher et al., CASE-CONTROL STUDY OF SERUM LIPOPROTEIN(A) AND APOLIPOPROTEIN-A-I ANDAPOLIPOPROTEIN-B IN STROKE IN THE YOUNG, Acta neurologica Scandinavica, 94(2), 1996, pp. 127-130
Objectives - Abnormalities of lipoprotein(a) and apolipoproteins A-I a
nd B are being recognised as independent risk factors in ischaemic hea
rt disease and atherosclerosis. There are no studies from India where
stroke in the young constitutes nearly 20-30% of all strokes. Subjects
and methods - Fasting serum lipids, lipoproteins, apolipoproteins A-I
and B and lipoprotein(a) were measured in 50 patients aged less than
40 years presenting with completed stroke and 50 normal, age and sex-m
atched control subjects. Apolipoproteins A-I and B were measured by im
munoturbidimetry and lipoprotein(a) by enzyme-linked immunosorbent ass
ay. Results - The serum total cholesterol, HDL-cholesterol, LDL-choles
terol, VLDL-cholesterol, triglycerides and apolipoproteins A-I and B w
ere not significantly different in the test group as compared to the c
ontrols. However, serum lipoprotein(a) was significantly higher in the
young stroke patients. Conclusion - These findings confirm the hypoth
esis that an elevated serum lipoprotein(a) level is an important risk
factor in the development of cerebral ischaemia in patients aged less
than 40 years It may be worthwhile to study whether it is useful in id
entifying patients most at risk for stroke.